| Marc A Schlosberg, PH D | |
|
8629 Bluejacket St, Suite 100, Lenexa, KS 66214-1604 | |
| (913) 677-3553 | |
| (913) 677-3282 |
| Full Name | Marc A Schlosberg |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 37 Years |
| Location | 8629 Bluejacket St, Lenexa, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043248594 | NPI | - | NPPES |
| 100240840A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 832 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clinical Associates Pa | 9739084112 | 15 |
News Archive
The final results of a six-month, multi-center, open-label Phase 3 study of VIAject® (more-rapid-acting injectable human insulin) versus regular human insulin (RHI) in 471 patients with type 2 diabetes were presented today by Helena Rodbard, M.D., at the 70th Scientific Sessions of the American Diabetes Association. Dr. Rodbard was a principal investigator of this study, which was designed to evaluate the safety and efficacy of VIAject® versus regular human insulin when used in combination with insulin glargine.
Cancer cells can develop resistance to therapy through both genetic and non-genetic mechanisms. But it is unclear how and why one of these routes to resistance prevails.
Malaria kills more than one million people every year so the news that an effective vaccine could be available within five years is more than welcome.
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
› Verified 9 days ago
| Entity Name | Clinical Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477588085 PECOS PAC ID: 9739084112 Enrollment ID: O20051029000300 |
News Archive
The final results of a six-month, multi-center, open-label Phase 3 study of VIAject® (more-rapid-acting injectable human insulin) versus regular human insulin (RHI) in 471 patients with type 2 diabetes were presented today by Helena Rodbard, M.D., at the 70th Scientific Sessions of the American Diabetes Association. Dr. Rodbard was a principal investigator of this study, which was designed to evaluate the safety and efficacy of VIAject® versus regular human insulin when used in combination with insulin glargine.
Cancer cells can develop resistance to therapy through both genetic and non-genetic mechanisms. But it is unclear how and why one of these routes to resistance prevails.
Malaria kills more than one million people every year so the news that an effective vaccine could be available within five years is more than welcome.
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marc A Schlosberg, PH D 8629 Bluejacket St, Suite 100, Lenexa, KS 66214-1604 Ph: (913) 677-3553 | Marc A Schlosberg, PH D 8629 Bluejacket St, Suite 100, Lenexa, KS 66214-1604 Ph: (913) 677-3553 |
News Archive
The final results of a six-month, multi-center, open-label Phase 3 study of VIAject® (more-rapid-acting injectable human insulin) versus regular human insulin (RHI) in 471 patients with type 2 diabetes were presented today by Helena Rodbard, M.D., at the 70th Scientific Sessions of the American Diabetes Association. Dr. Rodbard was a principal investigator of this study, which was designed to evaluate the safety and efficacy of VIAject® versus regular human insulin when used in combination with insulin glargine.
Cancer cells can develop resistance to therapy through both genetic and non-genetic mechanisms. But it is unclear how and why one of these routes to resistance prevails.
Malaria kills more than one million people every year so the news that an effective vaccine could be available within five years is more than welcome.
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
› Verified 9 days ago
Jimmie Gene Lemons, ED.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 15700 College Blvd, Suite 201, Lenexa, KS 66219 Phone: 913-383-8977 Fax: 913-383-3116 | |
Douglas Hippe, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 12805 W 100th Ter, Lenexa, KS 66215 Phone: 913-271-7899 Fax: 913-894-1329 | |
Donna Jane Dassel-stuke, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8325 Lenexa Dr Ste 150, Lenexa, KS 66214 Phone: 913-652-9229 | |
Ms. Alexandria L Kaplan, LMLP-T Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St Ste 100, Lenexa, KS 66214 Phone: 913-677-3553 | |
Ms. Cassandra Ann Thompson, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Suite 100, Lenexa, KS 66214 Phone: 913-677-3553 Fax: 913-677-3282 | |
Bambi Burgard, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Suite 102, Lenexa, KS 66214 Phone: 913-677-0500 Fax: 913-677-5243 |